Evaluation of DNA Methylation Array for Glioma Tumor Profiling and Description of a Novel Epi-Signature to Distinguish IDH1/IDH2 Mutant and Wild-Type Tumors.
Laila C SchenkelJoseph MathewHal W HirteJohn ProviasGuillaume ParéMichael ChongDaria GrafodatskayaElizabeth McCreadyPublished in: Genes (2022)
mutation status of gliomas, thus improving diagnostic yield and efficiency of laboratory testing compared to single analyte IDH1/IDH2 or 1p19q tests.